中文
| Catalogue |
| Recommend Products |
Company News
- AMSBIO: Understanding How Natural Killer Cells are Educated 8/26/2019
- AMSBIO Introduced a New Range of Homogeneous Proximity Assays 7/19/2019
- AMSBIO Announces the Extensive CAR-T Cell Range for Research & Immunotherapy 7/10/2019
- AMSBIO Reports on Investigating Cancer Resistance of the Naked Mole-Rat 7/2/2019
- AMSBIO's Partner ScreenIn3D Wins Technology Innovation Prize 6/24/2019
- AMSBIO: 3D Organoid Culture Crucial for Chromosome Segregation 5/31/2019
- AMSBIO Introduces High Performance Feeder-Free Medium for Pluripotent Stem Cell Culture 5/24/2019
- AMSBIO: Low Adhesion Plates Help Culture Light Responsive Retinal Organoids 5/4/2019
- AMSBIO Announces XerumFree™--Culturing Cells Without Using Serum 4/12/2019
- AMSBIO: New Tissue Microarrays Conform with FDA Standards 3/27/2019
- AMSBIO: Real-time Biochemistry of Living Cells and Whole Organisms 3/18/2019
- AMSBIO Provides the Detachin™ Cell Detachment Solution 2/28/2019
- AMSBIO: CRISPR/Cas9 Knockout Cell Lines and Lysates 2/14/2019
- AMSBIO: Noble Metal Coated Substrates for Nanotechnology Applications 1/30/2019
- AMSBIO: Embedded Chondroitinase ABC Shows Promise for Spinal Injury Treatment 1/8/2019
- AMSBIO Expands Wnt Signaling Pathway Product Portfolio 12/12/2018
- AMSBIO: High Yield Cell-Free Protein Expression Kit 11/30/2018
- AMSBIO: Induced Pluripotent Stem Cells for Regenerative Research 11/20/2018
- AMSBIO: Consistent High Quality Cell Line Controls 11/3/2018
- AMSBIO: Activator Cell Line for Immune Checkpoint Therapy Research 10/12/2018